{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:56:30Z","timestamp":1791190590164,"version":"4.1.0"},"reference-count":206,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cytotoxic chemotherapy remains an important component of multimodal treatment for many solid tumors, but resistance and dose-limiting toxicities continue to constrain clinical benefit. The gut microbiome can influence chemotherapy response through microbial drug biotransformation, metabolite signaling, intestinal-barrier integrity, systemic immune regulation, and tumor-cell stress and death pathways. Across solid tumors, the evidence is strongest in colorectal cancer, where clinical associations are supported by increasingly detailed mechanistic and interventional studies; evidence in many extraintestinal cancers remains less mature and is dominated by smaller observational cohorts and selected preclinical models. Importantly, gut-derived systemic effects should be distinguished from local or tumor-associated microbial mechanisms, and direct tumor-cell resistance should be separated from altered drug exposure and toxicity-mediated reductions in relative dose intensity. Microbiota-associated and metabolic biomarkers and microbiota-targeted interventions show potential for treatment stratification, toxicity prediction, and therapeutic modulation, but clinical translation remains limited by heterogeneous cohorts, incomplete causal validation, variable engraftment and strain specificity, and safety and standardization requirements. Overall, the microbiome is best viewed as a cancer- and regimen-specific modifier of chemotherapy rather than a universal determinant of response. Prospective, mechanism-matched studies are needed to establish whether microbiome-guided strategies can improve treatment efficacy, tolerance, and completion.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1945287","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:38:22Z","timestamp":1791189502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiome-shaped chemotherapy responses across cancer types: mechanisms of resistance, biomarkers, and targeted interventions"],"prefix":"10.3389","volume":"17","author":[{"given":"Ting","family":"Shao","sequence":"first","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Chifeng University","place":["Chifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Chifeng University","place":["Chifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Chifeng University","place":["Chifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pu","sequence":"additional","affiliation":[{"name":"General Office, Affiliated Hospital of Chifeng University","place":["Chifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Chifeng University","place":["Chifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Chifeng University","place":["Chifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1084\/jem.20180448","article-title":"The gut microbiome: Relationships with disease and opportunities for therapy","volume":"216","author":"Durack","year":"2019","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1600266","article-title":"The Human Intestinal Microbiome in Health and Disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41698-025-01034-0","article-title":"The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review","volume":"9","author":"B\u00f6hm","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","article-title":"Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy","volume":"164","author":"Chrysostomou","year":"2023","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme","volume":"330","author":"Wallace","year":"2010","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0479","article-title":"Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation","volume":"4","author":"Bukavina","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1186\/s12967-025-07226-3","article-title":"Fusobacterium nucleatum enhances oxaliplatin resistance in colon cancer by increasing PVT1 expression","volume":"23","author":"Gao","year":"2025","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2333790","article-title":"Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway","volume":"16","author":"Wang","year":"2024","journal-title":"Gut Microbes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2024.04.226","article-title":"Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin\/\u03b2-catenin\/GPX4 axis in colorectal cancer","volume":"220","author":"Li","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193247","article-title":"Fusobacterium nucleatum and Its Impact on Colorectal Cancer Chemoresistance: A Meta-Analysis of In Vitro Co-Culture Infections","volume":"17","author":"Risoen","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S145949","article-title":"Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage III\/IV colorectal cancer patients","volume":"10","author":"Yan","year":"2017","journal-title":"Onco Targets Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.chom.2025.05.004","article-title":"Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity","volume":"33","author":"Ding","year":"2025","journal-title":"Cell Host Microbe"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2320291","article-title":"The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance","volume":"16","author":"de Oliveira Alves","year":"2024","journal-title":"Gut Microbes"},{"key":"B21","first-page":"eadq8870","article-title":"Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.","volume-title":"Sci Transl Med.","author":"Trepka","year":"2025"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2024.24221","article-title":"The Impact and Mechanism of Action of Peptostreptococcus anaerobius on Chemotherapy Resistance in Human Colorectal Cancer","volume":"35","author":"Li","year":"2024","journal-title":"Turk J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1230681","article-title":"Deciphering the mechanism of Peptostreptococcus anaerobius-induced chemoresistance in colorectal cancer: the important roles of MDSC recruitment and EMT activation","volume":"14","author":"Gu","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105041","article-title":"Desulfovibrio desulfuricans and its derived metabolites confer resistance to FOLFOX through METTL3","volume":"102","author":"Li","year":"2024","journal-title":"EBioMedicine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-026-08756-4","article-title":"Klebsiella pneumoniae LPS drives stromal-mediated repression of p53 and colorectal cancer chemoresistance","volume":"17","author":"Fragkoulis","year":"2026","journal-title":"Cell Death Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12879-024-09133-2","article-title":"The pathogenicity of vancomycin-resistant Enterococcus faecalis to colon cancer cells","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0023025","DOI":"10.1128\/jb.00230-25","article-title":"Colorectal cancer-associated Streptococcus gallolyticus: a hidden diversity expose","volume":"207","author":"P\u00e9richon","year":"2025","journal-title":"J Bacteriol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1510851","article-title":"Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer","volume":"15","author":"Xu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157233","article-title":"Huang-Lian-Jie-Du decoction enhances Capecitabine-Oxaliplatin efficacy via Akkermansia muciniphila and CD8(+) T cells in colorectal cancer","volume":"148","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i8.108870","article-title":"Associations between serum biomarkers and gut microbial imbalance in predicting chemotherapy response in colorectal cancer: A retrospective analysis","volume":"17","author":"Ling","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1565661","article-title":"Gut microbiome with RAS mutation and chemotherapy response in patients with advanced or metastatic colorectal cancer: a pilot, exploratory study","volume":"15","author":"Kim","year":"2025","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40168-025-02133-7","article-title":"Lipid accumulation inhibition strategies alleviate Fusobacterium nucleatum-infected colorectal cancer","volume":"13","author":"Zhou","year":"2025","journal-title":"Microbiome"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1126808","article-title":"Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses","volume":"14","author":"Yu","year":"2023","journal-title":"Front Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199710","article-title":"Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications","volume":"26","author":"Incognito","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ccell.2025.09.010","article-title":"Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest","volume":"44","author":"Galeano Ni\u00f1o","year":"2026","journal-title":"Cancer Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13099-025-00757-6","article-title":"Fusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer","volume":"17","author":"Sadeghloo","year":"2025","journal-title":"Gut Pathog"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112152-20240719-00297","article-title":"Fusobacterium nucleatum upregulates ABCG2 by activating the E-cadherin\/\u03b2-catenin signaling pathway to promote oxaliplatin resistance in colorectal cancer","volume":"47","author":"Xu","year":"2025","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"B38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s12876-025-04293-0","article-title":"The pathobiont role of Akkermansia muciniphila in colorectal cancer: a systematic review","volume":"25","author":"Soheilipour","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-022-2201-1","article-title":"Extracellular vesicles derived from Lactobacillus plantarum restore chemosensitivity through the PDK2-mediated glucose metabolic pathway in 5-FU-resistant colorectal cancer cells","volume":"60","author":"An","year":"2022","journal-title":"J Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-021-0562-5","article-title":"GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABA(B) receptor signaling","volume":"59","author":"An","year":"2021","journal-title":"J Microbiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1605.05024","article-title":"Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells","volume":"26","author":"An","year":"2016","journal-title":"J Microbiol Biotechnol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10565-024-09889-y","article-title":"Novel therapeutic targets: bifidobacterium-mediated urea cycle regulation in colorectal cancer","volume":"40","author":"Nie","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12876-025-03923-x","article-title":"Effect of chitosan nanoparticles conjugated with the cell free supernatant of Bifidobacterium bifidum on the expression of genes related to colorectal cancer in colon adenocarcinoma (Caco-2) cell line","volume":"25","author":"Maqsoodi","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3648","article-title":"Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria","volume":"359","author":"Dejea","year":"2018","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101376","article-title":"Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells","volume":"5","author":"Sogari","year":"2024","journal-title":"Cell Rep Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1713614","article-title":"Microbiota-host metabolism reprogramming in colorectal cancer: from pathogenesis to precision therapies","volume":"15","author":"Guo","year":"2025","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","article-title":"Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression","volume":"7","author":"Nshanian","year":"2025","journal-title":"Nat Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031572","article-title":"Sodium Butyrate Inhibits the Expression of Thymidylate Synthase and Induces Cell Death in Colorectal Cancer Cells","volume":"25","author":"Kim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2023.09.028","article-title":"Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance","volume":"363","author":"Chen","year":"2023","journal-title":"J Control Release"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e70656","DOI":"10.1111\/jcmm.70656","article-title":"A Model of Butyrate Activity and Resistance in CRC","volume":"29","author":"Bordonaro","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-025-01058-7","article-title":"Enhancement of 5-fluorouracil efficacy in colorectal cancer cells through thymidylate synthase inhibition by sodium propionate","volume":"61","author":"Kim","year":"2025","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-022-1533-1","article-title":"Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells","volume":"60","author":"Kim","year":"2022","journal-title":"J Microbiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190810","article-title":"Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity","volume":"14","author":"Mowat","year":"2023","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332243","article-title":"Secondary bile acid production by gut bacteria promotes Western diet-associated colorectal cancer","volume":"75","author":"Osswald","year":"2026","journal-title":"Gut"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgl139","article-title":"Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells","volume":"28","author":"Payne","year":"2007","journal-title":"Carcinogenesis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030530","article-title":"Piperine Attenuates Lithocholic Acid-Stimulated Interleukin-8 by Suppressing Src\/EGFR and Reactive Oxygen Species in Human Colorectal Cancer Cells","volume":"11","author":"Li","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910209","article-title":"Lithocholic Acid Induces miR21, Promoting PTEN Inhibition via STAT3 and ERK-1\/2 Signaling in Colorectal Cancer Cells","volume":"22","author":"Nguyen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jare.2024.07.019","article-title":"Disturbance of bile acids profile aggravates the diarrhea induced by capecitabine through inhibiting the Wnt\/\u03b2-catenin pathway","volume":"72","author":"Wang","year":"2025","journal-title":"J Adv Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.5c01993","article-title":"Bile Acid-Induced Aggregation and Phase Separation of Mutant p53 Leads to Doxorubicin Sequestration","volume":"27","author":"Kaur","year":"2026","journal-title":"Biomacromolecules"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1604876","article-title":"Characteristic metabolite profile of 10 colorectal cancer-related bacteria","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114400","article-title":"Fusobacterium nucleatum-targeted polymeric micelles disrupting biofilm-immune crosstalk for precision colorectal cancer immunotherapy","volume":"388","author":"Wu","year":"2025","journal-title":"J Control Release"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010203108","article-title":"Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis","volume":"108","author":"Goodwin","year":"2011","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00414-19","article-title":"The Polyamine Spermidine Modulates the Production of the Bacterial Genotoxin Colibactin","volume":"4","author":"Chagneau","year":"2019","journal-title":"mSphere"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e2413241121","DOI":"10.1073\/pnas.2413241121","article-title":"Intestinal Lactobacillus murinus-derived small RNAs target porcine polyamine metabolism","volume":"121","author":"Fan","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12964-024-01552-7","article-title":"Tryptophan metabolism in digestive system tumors: unraveling the pathways and implications","volume":"22","author":"Yu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01314-6","article-title":"Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition","volume":"26","author":"Cui","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.62347\/xtrc3347","article-title":"IDO1-mediated kynurenine production inhibits IGFBP5 signaling to promote 5-fluorouracil-induced senescence escape and chemoresistance in colorectal cancer","volume":"14","author":"Li","year":"2024","journal-title":"Am J Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-18-0668","article-title":"IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis","volume":"79","author":"Bishnupuri","year":"2019","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329543","article-title":"Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis","volume":"72","author":"Fong","year":"2023","journal-title":"Gut"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0167722","DOI":"10.1128\/spectrum.01677-22","article-title":"Chemotherapeutic Drugs Induce Different Gut Microbiota Disorder Pattern and NOD\/RIP2\/NF-\u03baB Signaling Pathway Activation That Lead to Different Degrees of Intestinal Injury","volume":"10","author":"Huang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.62347\/xxcs3377","article-title":"Chemotherapy-induced suppression of colorectal cancer-associated gut microbiota and modulation of host miRNA expression","volume":"17","author":"Wang","year":"2025","journal-title":"Am J Transl Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s10020-025-01122-8","article-title":"High-salt diet decreases FOLFOX efficacy via gut bacterial tryptophan metabolism in colorectal cancer","volume":"31","author":"Deng","year":"2025","journal-title":"Mol Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00432-024-06028-2","article-title":"The role of gut microbial \u03b2-glucuronidases in carcinogenesis and cancer treatment: a scoping review","volume":"150","author":"Hillege","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00759-22","article-title":"Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury","volume":"10","author":"Zou","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-334699","article-title":"Bacteroides intestinalis mediates the sensitivity to irinotecan toxicity via tryptophan catabolites","volume":"75","author":"Hou","year":"2026","journal-title":"Gut"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41467-026-68741-5","article-title":"Kynurenine mediates the chemotherapy-induced intestinal toxicity through modulation of gut microbiota","volume":"17","author":"Xie","year":"2026","journal-title":"Nat Commun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107441","article-title":"Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT)","volume":"187","author":"Gridelli","year":"2024","journal-title":"Lung Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009256.pub3","article-title":"Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer","author":"Vasconcellos","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2969287","article-title":"Akkermansia muciniphila Enhances the Antitumor Effect of Cisplatin in Lewis Lung Cancer Mice","volume":"2020","author":"Chen","year":"2020","journal-title":"J Immunol Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9619","article-title":"Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination","volume":"7","author":"Jeon","year":"2016","journal-title":"Oncotarget"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28093","article-title":"Butyrate attenuates the stemness of lung cancer cells through lysosome Fe2+- and SLC7A11-mediated ferroptosis","volume":"10","author":"Bi","year":"2024","journal-title":"Heliyon"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194849","article-title":"Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer","volume":"14","author":"Bawaneh","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1021\/acsinfecdis.7b00166","article-title":"Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome","volume":"4","author":"Yan","year":"2018","journal-title":"ACS Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0455","article-title":"Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer","volume":"82","author":"Chambers","year":"2022","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","article-title":"Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring","volume":"41","author":"Colbert","year":"2023","journal-title":"Cancer Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"key":"B87","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/1759-7714.13711","article-title":"Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer","volume":"12","author":"Zhao","year":"2021","journal-title":"Thorac Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14199","article-title":"Intestinal flora characteristics of advanced non-small cell lung cancer in China and their role in chemotherapy based on metagenomics: A prospective exploratory cohort study","volume":"12","author":"Zhang","year":"2021","journal-title":"Thorac Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21037\/tlcr-2026-1-0209","article-title":"Gut microbiome in advanced non-small cell lung cancer: effect of chemotherapy and impact on efficacy","volume":"15","author":"Trachu","year":"2026","journal-title":"Transl Lung Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6446","article-title":"Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non-small cell lung cancer","volume":"12","author":"Sun","year":"2023","journal-title":"Cancer Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.07.032","article-title":"Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer","volume":"115","author":"Qiu","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad060","article-title":"Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy","volume":"28","author":"Vernaci","year":"2023","journal-title":"Oncologist"},{"key":"B93","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10549-024-07395-7","article-title":"Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14","volume":"208","author":"Nakamoto","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16030433","article-title":"Baseline Gut Microbiome and Metabolite Profiles Associate with Treatment Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy","volume":"16","author":"Liepina","year":"2026","journal-title":"Diagnostics"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.7150\/jca.46621","article-title":"Application of machine learning in prediction of Chemotherapy resistant of Ovarian Cancer based on Gut Microbiota","volume":"12","author":"Gong","year":"2021","journal-title":"J Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13163999","article-title":"Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome","volume":"13","author":"D'Amico","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B97","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s42003-021-01741-x","article-title":"Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation","volume":"4","author":"Sims","year":"2021","journal-title":"Commun Biol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1637098","article-title":"Microbiota-immune dysregulation in cervical cancer patients from Western Mexico: linking gut dysbiosis and NK cell exhaustion as promising biomarkers","volume":"16","author":"Klimov-Kravtchenko","year":"2025","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35229","article-title":"Gut microbiome in association with chemotherapy-induced toxicities among patients with breast cancer","volume":"130","author":"Nguyen","year":"2024","journal-title":"Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41523-024-00707-6","article-title":"Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer","volume":"10","author":"Otto-Dobos","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2026.106489","article-title":"Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and pain","volume":"135","author":"Beales","year":"2026","journal-title":"Brain Behav Immun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e71752","DOI":"10.1002\/cam4.71752","article-title":"The Role of Gut Microbiota and Their Derived Metabolites in Chemotherapy-Induced Nausea and Vomiting in Ovarian Cancer","volume":"15","author":"Zu","year":"2026","journal-title":"Cancer Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.12.040","article-title":"Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer","volume":"107","author":"Mitra","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B104","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-025-67169-7","article-title":"Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state","volume":"17","author":"Bersier","year":"2025","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.865121","article-title":"Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108373","article-title":"LCA, a bacterial metabolite, induces ferroptosis and senescence in triple-negative breast cancer","volume":"262","author":"Jin","year":"2025","journal-title":"Toxicon"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2026.02.026","article-title":"Role of the gut microbiome in shaping drug response in immunocompromised hosts","volume":"32","author":"Bejaoui","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17233783","article-title":"Gut Microbiota Signatures Associate with Chemotherapy-Related Adverse Events in Breast Cancer Patients","volume":"17","author":"Hsu","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2410475","article-title":"Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice","volume":"16","author":"Loman","year":"2024","journal-title":"Gut Microbes"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e39596","DOI":"10.1097\/MD.0000000000039596","article-title":"Analysis of the correlation between gut microbiome imbalance and the development of endometrial cancer based on metagenomics","volume":"103","author":"Xing","year":"2024","journal-title":"Medicine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ygyno.2020.09.010","article-title":"Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer","volume":"159","author":"Chambers","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S265205","article-title":"Changes of Intestinal Microbiota in Ovarian Cancer Patients Treated with Surgery and Chemotherapy","volume":"12","author":"Tong","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e0130123","DOI":"10.1128\/msystems.01301-23","article-title":"Gut-derived metabolite 3-methylxanthine enhances cisplatin-induced apoptosis via dopamine receptor D1 in a mouse model of ovarian cancer","volume":"9","author":"Mai","year":"2024","journal-title":"mSystems"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0247905","DOI":"10.1371\/journal.pone.0247905","article-title":"A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers","volume":"16","author":"El Alam","year":"2021","journal-title":"PloS One"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e2500036","DOI":"10.1200\/GO-25-00036","article-title":"Cervical and Tumor-Associated Microbiomes in Botswana Women With and Without HIV With Carcinoma of the Cervix Before and After Definitive Chemoradiation","volume":"11","author":"Sims","year":"2025","journal-title":"JCO Glob Oncol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082795","article-title":"Effect of Diet and Dietary Components on the Composition of the Gut Microbiota","volume":"13","author":"Beam","year":"2021","journal-title":"Nutrients"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01283","article-title":"Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial","volume":"43","author":"Petrylak","year":"2025","journal-title":"J Clin Oncol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15434","article-title":"Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration","volume":"128","author":"Ravi","year":"2021","journal-title":"BJU Int"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15666","article-title":"Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer","volume":"114","author":"Miyake","year":"2023","journal-title":"Cancer Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105632","article-title":"57P Multi-matrix untargeted metabolomics profiling reveals potential non-invasive prognostic and predictive biomarkers in metastatic colorectal cancer: The CRC-Tsen study","volume":"10","author":"Bignante","year":"2025","journal-title":"ESMO Open"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.08.060","article-title":"Tumour-specific delivery of \u03c9-conotoxin MVIIA via engineered Salmonella for safe anticancer therapy","volume":"84","author":"Kim","year":"2026","journal-title":"J Adv Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2881-9","article-title":"Host variables confound gut microbiota studies of human disease","volume":"587","author":"Vujkovic-Cvijin","year":"2020","journal-title":"Nature"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2024.110951","article-title":"Metagenomic analysis reveals effects of gut microbiome in response to neoadjuvant chemoradiotherapy in advanced rectal cancer","volume":"116","author":"Chen","year":"2024","journal-title":"Genomics"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179549","article-title":"Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients","volume":"22","author":"Sanchez-Alcoholado","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010026","article-title":"Potential Impact of Microbial Dysbiosis and Tryptophan Metabolites in Advanced Stages of Colorectal Cancer","volume":"14","author":"Hulin","year":"2026","journal-title":"Biomedicines"},{"key":"B128","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1038\/s41598-023-40020-z","article-title":"Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes","volume":"13","author":"Luo","year":"2023","journal-title":"Sci Rep"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i6.106393","article-title":"Analysis of serum S100A12, soluble advanced glycation end products receptor, and gut microbiome in elderly patients with colorectal cancer","volume":"17","author":"Qiao","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41591-024-02823-z","article-title":"A gut microbial signature for combination immune checkpoint blockade across cancer types","volume":"30","author":"Gunjur","year":"2024","journal-title":"Nat Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2452277","article-title":"From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy","volume":"17","author":"Lin","year":"2025","journal-title":"Gut Microbes"},{"key":"B132","doi-asserted-by":"publisher","first-page":"13531","DOI":"10.1038\/s41598-026-43626-1","article-title":"Capecitabine combined with fecal microbiota transplantation prevents colorectal cancer progression through correction of microbial dysbiosis and immune regulation","volume":"16","author":"Arshad","year":"2026","journal-title":"Sci Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114525105503","article-title":"Protective effects of a probiotic yoghurt in a murine model of breast cancer undergoing chemotherapy","volume":"134","author":"Cerasuolo","year":"2025","journal-title":"Br J Nutr"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1002\/imt2.213","article-title":"The challenge and opportunity of gut microbiota-targeted nanomedicine for colorectal cancer therapy","volume":"3","author":"Wei","year":"2024","journal-title":"Imeta"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.06.042","article-title":"Antibacterial tellurium-containing polycarbonate drug carriers to eliminate intratumor bacteria for synergetic chemotherapy against colorectal cancer","volume":"185","author":"Hu","year":"2024","journal-title":"Acta Biomater"},{"key":"B136","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2023.11.018","article-title":"Size-tunable nanogels for cascaded release of metronidazole and chemotherapeutic agents to combat Fusobacterium nucleatum-infected colorectal cancer","volume":"365","author":"Xie","year":"2024","journal-title":"J Control Release"},{"key":"B137","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12951-020-00758-4","article-title":"Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA","volume":"19","author":"Zhang","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jconrel.2023.02.001","article-title":"ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models","volume":"355","author":"Kim","year":"2023","journal-title":"J Control Release"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.synbio.2024.09.001","article-title":"Engineered probiotic-mediated intratumoral delivery and controlled release of bacterial collagenase for cancer therapy","volume":"10","author":"Li","year":"2025","journal-title":"Synth Syst Biotechnol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0070","article-title":"Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma","volume":"25","author":"Hassan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12896-026-01122-4","article-title":"Nanoparticles co-loaded with bacillus Calmette-Gu\u00e9rin pure protein derivative and doxorubicin for bladder tumor therapy","volume":"26","author":"Zhang","year":"2026","journal-title":"BMC Biotechnol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177533","article-title":"To explore the potential combined treatment strategy for colorectal cancer: Inhibition of cancer stem cells and enhancement of intestinal immune microenvironment","volume":"998","author":"Xu","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27031438","article-title":"Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts","volume":"27","author":"Unrug-Bielawska","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020386","article-title":"Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil\/Oxaliplatin-Induced Toxicity in Colorectal Cancer","volume":"21","author":"Chang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.122.221890","article-title":"Fecal microbial SN-38G metabotypes in colorectal cancer patients are associated with irinotecan-induced delayed diarrhea","volume":"385","author":"Wu","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2319511","article-title":"Chemotherapy-induced microbiota exacerbates the toxicity of chemotherapy through the suppression of interleukin-10 from macrophages","volume":"16","author":"He","year":"2024","journal-title":"Gut Microbes"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07024-z","article-title":"Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy","volume":"67","author":"Mendelsohn","year":"2022","journal-title":"Dig Dis Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04189-2","article-title":"Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial","volume":"32","author":"Porcari","year":"2026","journal-title":"Nat Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/nu15020356","article-title":"Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients","volume":"15","author":"Huang","year":"2023","journal-title":"Nutrients"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31907","article-title":"A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma","volume":"125","author":"Jiang","year":"2019","journal-title":"Cancer"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2026.06.016","article-title":"PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy","volume":"211","author":"Chambers","year":"2026","journal-title":"Gynecol Oncol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319548","article-title":"International consensus conference on stool banking for faecal microbiota transplantation in clinical practice","volume":"68","author":"Cammarota","year":"2019","journal-title":"Gut"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N Engl J Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1272754","article-title":"Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeutics","volume":"14","author":"Spacova","year":"2023","journal-title":"Front Microbiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-024-01542-5","article-title":"Efficacy of probiotics or synbiotics supplementation on chemotherapy-induced complications and gut microbiota dysbiosis in gastrointestinal cancer: a systematic review and meta-analysis","volume":"79","author":"Yao","year":"2025","journal-title":"Eur J Clin Nutr"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.30476\/ijms.2024.102396.3530","article-title":"Investigation of Lactobacillus Probiotics Derived from Traditional Dairy Products in Eliciting Anti-Tumor Responses in Mouse Colorectal Cancer Model","volume":"50","author":"Rezai","year":"2025","journal-title":"Iran J Med Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-024-10405-1","article-title":"Probiotic Mixture Attenuates Colorectal Tumorigenesis in Murine AOM\/DSS Model by Suppressing STAT3, Inducing Apoptotic p53 and Modulating Gut Microbiota","volume":"17","author":"Leung","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1080\/01635580903407197","article-title":"Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis","volume":"62","author":"Baldwin","year":"2010","journal-title":"Nutr Cancer"},{"key":"B163","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11274-024-03929-9","article-title":"The anticancer effect of potential probiotic L. fermentum and L. plantarum in combination with 5-fluorouracil on colorectal cancer cells","volume":"40","author":"Salek","year":"2024","journal-title":". World J Microbiol Biotechnol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00983","article-title":"Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil\/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model","volume":"9","author":"Chang","year":"2018","journal-title":"Front Microbiol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s11658-025-00850-3","article-title":"Combination of Tripterygium glycosides and Lactobacillus paracasei sensitises epithelial ovarian cancer to cisplatin via downregulating Keap1-Nrf2-GPX4 signalling pathway","volume":"31","author":"Tian","year":"2026","journal-title":"Cell Mol Biol Lett"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/nu14132559","article-title":"Effects of Dietary Fibers on Short-Chain Fatty Acids and Gut Microbiota Composition in Healthy Adults: A Systematic Review","volume":"14","author":"Vinelli","year":"2022","journal-title":"Nutrients"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fsufs.2022.887642","article-title":"Postbiotics: From emerging concept to application","volume":"6","author":"Aggarwal","year":"2022","journal-title":"Front Sustain Food Syst"},{"key":"B169","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12866-024-03384-4","article-title":"Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon","volume":"24","author":"Ziemons","year":"2024","journal-title":"BMC Microbiol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e2403587","DOI":"10.1002\/adhm.202403587","article-title":"5-Fluorouracil Loaded Prebiotic-Probiotic Liposomes Modulating Gut Microbiota for Improving Colorectal Cancer Chemotherapy","volume":"14","author":"Sun","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1039\/d5nr01337b","article-title":"A prebiotic inulin derivative-containing liposome for oral berberine delivery improves the orthotopic colorectal cancer chemotherapy","volume":"17","author":"Xia","year":"2025","journal-title":"Nanoscale"},{"key":"B172","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12916-025-04233-5","article-title":"Mitigation of chemotherapy-induced gut dysbiosis and diarrhea by supplementation with heat-killed Bacteroides fragilis","volume":"23","author":"Yan","year":"2025","journal-title":"BMC Med"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14111282","article-title":"Exploring the Anticancer Potential of the Multistrain Probiotic Formulation OxxySlab in Bladder Cancer Cell Lines","volume":"14","author":"Ciummo","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2017.09.007","article-title":"Shared mechanisms among probiotic taxa: implications for general probiotic claims","volume":"49","author":"Sanders","year":"2018","journal-title":"Curr Opin Biotechnol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0626-9","article-title":"Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients","volume":"25","author":"Yelin","year":"2019","journal-title":"Nat Med"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17070820","article-title":"Phage Therapy in Managing Multidrug-Resistant (MDR) Infections in Cancer Therapy: Innovations, Complications, and Future Directions","volume":"17","author":"Mafe","year":"2025","journal-title":"Pharmaceutics"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1721411","article-title":"Bacteriophage FNU1 negates Fusobacterium nucleatum induced cell growth, migration and chemotherapy resistance in gastrointestinal cancer cells","volume":"15","author":"Kabwe","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"25595","DOI":"10.1038\/s41598-026-56205-1","article-title":"Bacteriophage-mediated restoration of epithelial integrity, DNA damage response, and transcriptomic homeostasis in colon organoids exposed to ETBF and pks + E","volume":"16","author":"Song","year":"2026","journal-title":"coli. Sci Rep"},{"key":"B180","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12866-026-04737-x","article-title":"Large-genome phage vB_Eco_ZCEC15 targets gastrointestinal MDR E. coli: evidence from in vitro and Caco-2 cell models","volume":"26","author":"Essam","year":"2026","journal-title":"BMC Microbiol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0423-2","article-title":"Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy","volume":"3","author":"Zheng","year":"2019","journal-title":"Nat BioMed Eng"},{"key":"B182","doi-asserted-by":"publisher","first-page":"9534","DOI":"10.1038\/s41598-023-36749-2","article-title":"Potential of bacteriophage therapy in managing Staphylococcus aureus infections during chemotherapy for lung cancer patients","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"B183","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","article-title":"Targeting the gut and tumor microbiota in cancer","volume":"28","author":"Park","year":"2022","journal-title":"Nat Med"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B186","doi-asserted-by":"publisher","first-page":"e06486","DOI":"10.1002\/advs.202406486","article-title":"Self-Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery","volume":"12","author":"Zou","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114265","article-title":"Dual-responsive engineered bacteria with spatiotemporal controlled release of Cytolysin-A for oral management of colorectal cancer","volume":"387","author":"Chen","year":"2025","journal-title":"J Control Release"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03504-y","article-title":"Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella","volume":"44","author":"Tran","year":"2025","journal-title":"Oncogene"},{"key":"B189","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.chembiol.2024.10.013","article-title":"A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden","volume":"32","author":"Rebeck","year":"2025","journal-title":"Cell Chem Biol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.11.019","article-title":"Advanced photodynamic therapy with an engineered M13 phage targeting EGFR: Mitochondrial localization and autophagy induction in ovarian cancer cell lines","volume":"179","author":"Bortot","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1039\/d5nr01826a","article-title":"Phage-augmented casein nanocarriers for targeted bioimaging and enhanced combinatorial therapy of triple-negative breast cancer","volume":"17","author":"Pogu","year":"2025","journal-title":"Nanoscale"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114291","article-title":"Engineered tumor-symbiotic bacterial membrane nanovesicles enable precise immuno-chemotherapy of colorectal cancer","volume":"388","author":"Lu","year":"2025","journal-title":"J Control Release"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.02.013","article-title":"Multifunctional nanodrug for simultaneously combating chemoresistance and immunosuppression in Fusobacterium nucleatum-associated colorectal cancer","volume":"195","author":"Li","year":"2025","journal-title":"Acta Biomater"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.5c01170","article-title":"Multifunctional Nanoplatform Combining Photothermal Therapy and Chemoimmunotherapy for the Treatment of Escherichia coli-Colonized Colorectal Cancer","volume":"26","author":"Li","year":"2025","journal-title":"Biomacromolecules"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148499","article-title":"Nanotechnology approach to combat cancer-inducing Escherichia coli: Co-delivery of 5-fluorouracil and ciprofloxacin by chitosan-coated liposomes","volume":"332","author":"de Souza","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2025.06.046","article-title":"Oral oncolytic magnetotactic bacteria elicit anti-colorectal tumor immunity and reprogram microbiota metabolism","volume":"51","author":"Jiang","year":"2025","journal-title":"Bioact Mater"},{"key":"B197","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41467-022-28163-5","article-title":"Genetically stable CRISPR-based kill switches for engineered microbes","volume":"13","author":"Rottinghaus","year":"2022","journal-title":"Nat Commun"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-017-0084-4","article-title":"Metatranscriptome of human faecal microbial communities in a cohort of adult men","volume":"3","author":"Abu-Ali","year":"2018","journal-title":"Nat Microbiol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04567-7","article-title":"Environmental factors shaping the gut microbiome in a Dutch population","volume":"604","author":"Gacesa","year":"2022","journal-title":"Nature"},{"key":"B200","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41467-022-28034-z","article-title":"Microbiome differential abundance methods produce different results across 38 datasets","volume":"13","author":"Nearing","year":"2022","journal-title":"Nat Commun"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02035-2","article-title":"Guidelines for preventing and reporting contamination in low-biomass microbiome studies","volume":"10","author":"Fierer","year":"2025","journal-title":"Nat Microbiol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.12.025","article-title":"Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents","volume":"180","author":"Walter","year":"2020","journal-title":"Cell"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"B205","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01552-x","article-title":"Reporting guidelines for human microbiome research: the STORMS checklist","volume":"27","author":"Mirzayi","year":"2021","journal-title":"Nat Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1945287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:38:26Z","timestamp":1791189506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1945287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":206,"alternative-id":["10.3389\/fimmu.2026.1945287"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1945287","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1945287"}}